Frank Bernier on Nature Aging Breakthrough: Urolithin A Just Scored a Big Win for Immune Aging
Frank Bernier, R&D Unit Leader at GLICO, posted on LinkedIn:
”Urolithin A just scored a big win for immune aging.
A new randomized, double-blind, placebo-controlled trial in Nature Aging asked a simple question: if we improve mitochondrial quality, can we make aging immune cells act young again?
Healthy middle-aged adults took Urolithin A (1,000 mg/day) for 4 weeks. The results:
• ↑ Naive-like CD8⁺ T cells
• ↓ Terminally exhausted CD8⁺ T cells
• ↑ Fatty acid oxidation capacity in CD8⁺ T cells
• ↑ Mitochondrial biogenesis in immune cells
• ↑ NK cells and nonclassical monocytes
• Better functional responses (TNF secretion, bacterial uptake)
In other words: tuning mitophagy and mitochondria did not just support immunity in theory. It shifted real human immune cell phenotypes toward a more resilient, “younger” state in weeks.
Longevity is not only about adding years. It is about preserving immune memory, surveillance, and metabolic fitness so the system can still recognise, respond, and repair.
For anyone working in nutrition, microbiome, or healthy aging, this is a strong signal: mitochondria are not a side character. They are a primary target.
Article (Open Access) here.”
Title: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Authors: Dominic Denk, Anurag Singh, Herbert G. Kasler, Davide D’Amico, Julia Rey, Lucía Alcober-Boquet, Johanna M. Gorol, Christoph Steup, Ritesh Tiwari, Ryan Kwok, Rafael J. Argüello, Julie Faitg, Kathrin Sprinzl, Stefan Zeuzem, Valentina Nekljudova, Sibylle Loibl, Eric Verdin, Chris Rinsch, Florian R. Greten

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026